Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Chromatin accessibility at G-quadruplex-forming loci is associated with therapeutic target gene expression across cancer cell lines.

Created on 20 Nov 2026

Authors

Huiling Shu, Nan Weng, Tiantong Tao, Ke Xiao, Xiao Sun

Published in

Epigenetics. Volume 21. Issue 1. Pages 2765623. Dec 31, 2026. Epub Nov 20, 2026.

Abstract

G-quadruplexes (G4s) are implicated in transcriptional regulation, but their relationships with therapeutic target gene expression and cancer drug response remain incompletely understood. Here, we integrated multi-omics datasets to investigate these associations across cancer cell lines. We curated drug sensitivity-expression-associated target (SEAT) genes and found their enrichment in receptor tyrosine kinase (RTK)-centered signaling pathways. Using previously published G4-seq data, we characterized observed G4s (oG4s) and identified accessible G4-forming loci (AccG4s) by intersecting oG4s with cancer cell line-specific accessible chromatin regions. Their potential biological relevance was further assessed using EndoQuad annotations and evolutionary conservation. Multivariable analyses across 70 SEAT genes and 189 cancer cell lines revealed a positive association between AccG4 fraction and gene expression after adjustment for general accessibility, GC content and cancer lineage. We further identified 98 expression-associated AccG4s across 31 SEAT genes, predominantly located near transcription start sites and overlapping cis-regulatory elements. Exploratory drug response analyses revealed associations in selected drug-target combinations, but these were attenuated after adjustment for target gene expression, and none of the three representative associations remained significant after additional adjustment for cancer lineage. Collectively, our findings highlight associations between chromatin accessibility at G4-forming loci and therapeutic target gene expression, providing a computational, hypothesis-generating framework for investigating their potential relevance to cancer drug response.

PMID:
43059480
Bibliographic data and abstract were imported from PubMed on 20 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 1
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement